Live Breaking News & Updates on Retinal Gene Therapy Research

Stay updated with breaking news from Retinal gene therapy research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Australia's first investigational gene therapy trials for dry age-related macular degeneration under way


Centre for Eye Research Australia
Australia’s first clinical trials of an investigational gene therapy to treat dry age-related macular degeneration (AMD) have begun at the Centre for Eye Research Australia (CERA).
CERA’s Principal Investigator of Retinal Gene Therapy Research and vitreoretinal surgeon Dr Tom Edwards performed the first surgeries to administer the investigational gene therapy to patients at the Royal Victorian Eye and Ear Hospital in Melbourne.
This investigational gene therapy, being developed by Gyroscope Therapeutics Limited, is being studied in two studies evaluating its safety and effectiveness for the treatment of geographic atrophy (GA) secondary to AMD. ....

Tom Edwards , Gyroscope Therapeutics , Centre For Eye Research Australia , Principal Investigator Of Retinal Gene Therapy Research , Eye Research Australia , Retinal Gene Therapy Research , Royal Victorian Eye , Ear Hospital , Gyroscope Therapeutics Limited , டோம் எட்வர்ட்ஸ் , கைரோஸ்கோப் சிகிச்சை , மையம் க்கு கண் ஆராய்ச்சி ஆஸ்திரேலியா , கண் ஆராய்ச்சி ஆஸ்திரேலியா , அரச விக்டோரியன் கண் , காது மருத்துவமனை , கைரோஸ்கோப் சிகிச்சை வரையறுக்கப்பட்டவை ,